Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sebaceous Cell Tumor of Eyelid 1Prostatic Neoplasms 1Prostate cancer, familial 1Genetic Predisposition to Disease 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Exome × Clear all
NCT06080009 2024-02-23

Analysis of Molecular Biomarkers in Periocular Adnexal Tumours

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Unknown
20 enrolled

Sebaceous Cell Tumor of Eyelid

NCT05681416 2023-01-12

ProFam-Risk

Heinrich-Heine University, Duesseldorf

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Prostate cancer, familial, Prostatic Neoplasms, Genetic Predisposition to Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡